KPTI EPS Estimates
Karyopharm Therapeutics Inc.
$0.32
-$0.11(-26.30%)
31
Overall
40
Value
9
Tech
44
Quality
Market Cap
$7.14M
Volume
2.04M
52W Range
$0.57 - $10.99
Target Price
$8.80
KPTI EPS estimates: the consensus estimate for Karyopharm Therapeutics Inc.'s current fiscal year is -$4.70 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KPTI EPS Estimates
- EPS estimate, current quarter
- $-1.15
- EPS estimate, next quarter
- $-1.08
- EPS estimate, current year
- $-4.70
- EPS estimate, next year
- $-2.33
- EPS growth, 3-year
- +16.05%
| Fiscal year | EPS |
|---|---|
| 2025 | $-17.93 |
| 2024 | $-9.45 |
| 2023 | $-18.75 |
| 2022 | $-30.30 |
| 2021 | $-24.75 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KPTI | $0.32 | -26.3% | 2.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Karyopharm Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW